Embecta(us:EMBC)

    20.23

    +1.30%

    Updated on 2024-12-22

    Open:19.70
    Close:20.23
    High:20.44
    Low:19.30
    Pre Close:19.97
    Volume:1.41M
    Amount:28.43M
    Turnover:2.42%
    Shares:58.13M
    MarketCap:1.18B
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-303945581714996.78%4591151
    2024-03-313845521269795.75%3775167
    2023-12-314015535092696.14%4381167
    2023-09-304075604993397.76%3379184
    2023-06-304445387473194.02%3275209
    2023-03-314695540850496.72%5369224
    2022-12-3148357802622101.03%5289213
    2022-09-305105404732694.73%5668255
    dateorgNametotalratiochangeShareschangeRatio
    2024-06-30Blackrock Inc.919407215.94%-83319-0.90%
    2024-06-30Vanguard Group Inc728835912.64%743671.03%
    2024-06-30River Road Asset Management, Llc35836906.21%1368043.97%
    2024-06-30Millennium Management Llc34425325.97%2083016.44%
    2024-06-30American Century Companies Inc31630735.48%189330.60%
    2024-06-30Yacktman Asset Management Lp28153864.88%-1042-0.04%
    2024-06-30Deerfield Management Company, L.P. (Series C)27261354.73%0
    2024-06-30Fmr Llc24146024.19%101980.42%
    2024-06-30State Street Corp23243574.03%-195721-7.77%
    2024-06-30Geode Capital Management, Llc13420452.33%339832.60%

    About

    Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.
    Address:300 Kimball Drive,Suite 300

    Market Movers